Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01275820 · ClinicalTrials.gov registry record

A Study to Evaluate Glucose and Insulin Response to Nutralin

A clinical trial of Diabetes, sponsored by Avera McKennan Hospital & University Health Center.

Completed
Registry status
10
Enrollment target
1
Study location

NCT01275820: Completed study of Diabetes, sponsored by Avera McKennan Hospital & University Health Center.

NCT01275820 is a study of Diabetes that has completed, run by Avera McKennan Hospital & University Health Center. The registered enrollment target is 10 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01275820, a study of Diabetes, has completed, sponsored by Avera McKennan Hospital & University Health Center.

COMPLETED
Registry status
10 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate how an investigational food product affects a healthy person's blood sugar and insulin levels.

Primary Outcome

Measure the change in blood sugar levels

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Nutralin

Study Locations (1)

South Dakota

  • Avera Research Institute - Sioux Falls

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2010-06
Est. Completion 2010-09

What the finished NCT01275820 record still lists

NCT01275820 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (100% lower).

The record links to 1 condition, with Diabetes appearing as the primary indexed condition, and to 1 intervention - of which Nutralin is the first listed.

NCT01275820 reports a single indexed study location in South Dakota.

Frequently Asked Questions

What is clinical trial NCT01275820 about?

NCT01275820 is a clinical study titled "A Study to Evaluate Glucose and Insulin Response to Nutralin". The purpose of this study is to evaluate how an investigational food product affects a healthy person's blood sugar and insulin levels.

What is the current status of trial NCT01275820?

This trial is currently completed. The enrollment target is 10 participants. The study started on 2010-06. Estimated completion is 2010-09.

What conditions does trial NCT01275820 study?

This clinical trial studies the following conditions: Diabetes.

What interventions are being tested in trial NCT01275820?

The interventions under investigation include: Nutralin (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT01275820?

This trial is sponsored by Avera McKennan Hospital & University Health Center, which has 20 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01275820 being conducted?

This trial has 1 study location across South Dakota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01275820's enrollment target sits among peer trials

10 330th of 338 higher than 5 of 338 other Diabetes trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01275820, the US trial registry maintained by the National Library of Medicine. NCT01275820 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.